A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Recruiting · NCT07021898 · Registry updated 2025-12-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2025-12-03 | NCT07021898 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Erasca, Inc. | 5 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| NEXT Oncology | San Antonio | United States | 70 |
| NEXT Oncology | Irving | United States | 11 |
| Sarah Cannon Research Institute (SCRI) Oncology Partners | Nashville | United States | 1 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |